Cargando…
Cost Evaluation of Evidence-Based Treatments
Many treatment programs have adopted or are considering adopting evidence-based treatments (EBTs). When a program evaluates whether to adopt a new intervention, it must consider program objectives, operational goals, and costs. This article examines cost concepts, cost estimation, and use of cost in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Institute on Drug Abuse
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120119/ https://www.ncbi.nlm.nih.gov/pubmed/22002453 |
_version_ | 1782206617763184640 |
---|---|
author | Sindelar, Jody L. Ball, Samuel A. |
author_facet | Sindelar, Jody L. Ball, Samuel A. |
author_sort | Sindelar, Jody L. |
collection | PubMed |
description | Many treatment programs have adopted or are considering adopting evidence-based treatments (EBTs). When a program evaluates whether to adopt a new intervention, it must consider program objectives, operational goals, and costs. This article examines cost concepts, cost estimation, and use of cost information to make the final decision on whether to adopt an EBT. Cost categories, including variable and fixed, accounting and opportunity, and costs borne by patients and others, are defined and illustrated using the example of expenditures for contingency management. Ultimately, cost is one consideration in the overall determination of whether implementing an EBT is the best use of a program’s resources. |
format | Online Article Text |
id | pubmed-3120119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | National Institute on Drug Abuse |
record_format | MEDLINE/PubMed |
spelling | pubmed-31201192011-06-22 Cost Evaluation of Evidence-Based Treatments Sindelar, Jody L. Ball, Samuel A. Addict Sci Clin Pract Clinical Perspective Many treatment programs have adopted or are considering adopting evidence-based treatments (EBTs). When a program evaluates whether to adopt a new intervention, it must consider program objectives, operational goals, and costs. This article examines cost concepts, cost estimation, and use of cost information to make the final decision on whether to adopt an EBT. Cost categories, including variable and fixed, accounting and opportunity, and costs borne by patients and others, are defined and illustrated using the example of expenditures for contingency management. Ultimately, cost is one consideration in the overall determination of whether implementing an EBT is the best use of a program’s resources. National Institute on Drug Abuse 2010-12 /pmc/articles/PMC3120119/ /pubmed/22002453 Text en |
spellingShingle | Clinical Perspective Sindelar, Jody L. Ball, Samuel A. Cost Evaluation of Evidence-Based Treatments |
title | Cost Evaluation of Evidence-Based Treatments |
title_full | Cost Evaluation of Evidence-Based Treatments |
title_fullStr | Cost Evaluation of Evidence-Based Treatments |
title_full_unstemmed | Cost Evaluation of Evidence-Based Treatments |
title_short | Cost Evaluation of Evidence-Based Treatments |
title_sort | cost evaluation of evidence-based treatments |
topic | Clinical Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120119/ https://www.ncbi.nlm.nih.gov/pubmed/22002453 |
work_keys_str_mv | AT sindelarjodyl costevaluationofevidencebasedtreatments AT ballsamuela costevaluationofevidencebasedtreatments |